Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Friday, September 15, 2023
12:30 PM – 1:15 PM .
This session is supported by an independent educational grant from Bristol Myers Squibb.
Learning Objectives:
Describe the mechanisms of action of S1PR modulators and the implications for IBD management
Evaluate the most current clinical data associated with available and emerging S1PR modulators
Implement personalized treatment plans for patients with IBD by incorporating appropriate predictive biomarker analysis, improving patient communication, and addressing barriers to adherence